Effect of Lixelle on upper limb disorders

Evaluation of adsorption type blood purifier Lixelle by upper limb disorder evaluation table DASH - Evaluation of adsorption type blood purifier Lixelle by upper limb disorder evaluation table DASH

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCTs032180390

Enrollment

Registered

2019-03-20

Start date

2017-06-19

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dialysis related amyloidosis amyloidosis

Interventions

Use one Lixelle for each hemodialysis and continue treatment for one year

D006435

Lixelle

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients satisfying insurance application criteria of Lixelle (over 10 years of dialysis history, history of carpal tunnel opening procedure, confirmation of bone cysts, amyloid deposition, pain)

Exclusion criteria

Exclusion criteria: Patients who underwent open carpal tunnel within 3 months Patients who can not answer the DASH questionnaire Patients judged inappropriate by the research director

Design outcomes

Primary

Measure	Time frame
Change in DASH score	—

Secondary

Measure	Time frame
Change in grip strength Change in pain Change in TUAGT Change in range of motion of joint Changes in blood collection data	—

Contacts

Public ContactKoji Wakayama

Wakayama Dialysis Clinic

wakayama0727@gmail.com+81-3-6304-8511

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026